Revolution Medicines (NASDAQ:RVMD – Free Report) had its price objective cut by Stifel Nicolaus from $78.00 to $64.00 in a research report released on Tuesday,Benzinga reports. They currently have a ...
Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced 11 oral and poster presentations ...
Most analysts love Revolution Medicines, which has an average rating of buy. But there's reason to believe the stock may be overvalued at today's price of $34.72 per share. Let's look at the ...
We recently compiled a list of the 10 Best Debt Free Mid Cap Stocks to Buy Now. In this article, we are going to take a look ...
To listen to a live webcast of any of these events, or access archived webcasts, please visit: https://ir.revmed.com/events-and-presentations. Following the live webcasts, replays will be available on ...
4d
Quantbot Technologies LP bought a new position in shares of Revolution Medicines, Inc. (NASDAQ:RVMD – Free Report) during the ...
We recently published a list of the 10 Best Mid Cap Biotech Stocks to Buy. In this article, we are going to take a look at ...
The promise of affordable, quality medicine for everyone is within reach, but only if we dare to confront the obstacles and ...
7d
Dubai is reinventing healthcare — from AI-powered diagnostics to pharmaceutical manufacturing — and India’s tech, wellness, ...
Jonathan Ruane says the impact of AI is already being felt broadly: the number of job postings in the US for software ...
AI in robotic surgery, check-ups, and other medical niches is transforming the healthcare industry, bringing faster diagnostics, more precise treatments, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback